ARCHIVES

Letrozole Combination Increases PFS In ER+ and HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

NCCAM Trial Tests Electroacupuncture for Delayed Nausea.

June 14, 2002

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

September 20, 2013

CGAP Speeding Gene Discovery

April 30, 1999

HHS, NIH To Help Houston Rebuild Research Facilities.

July 13, 2001

Potti Claimed Rhodes Credential in Bio Submitted for DOD Funding

July 30, 2010

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996